Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Bexagliflozin Drug/Drug Interaction Study With Digoxin [Phase 1]
Phase 1 study assessing drug–drug interaction between Bexagliflozin and digoxin completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Safety and Efficacy of Different Oral Doses of BAY94-8862 in Japanese Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy (ARTS-DN Japan) [Phase 2]
Phase 2 trial update evaluating safety and efficacy of different oral doses of BAY94-8862 in Japanese subjects with type 2 diabetes and diab…
-
CLINICAL_TRIALS trial_result · 2021-07-16Clinical Trial Update: Effect of Behavioral Lifestyle Intervention on Frailty in Older Adults With Diabetes [NA]
A completed clinical trial evaluating whether a behavioral lifestyle intervention impacts frailty in older adults with type 2 diabetes, with…
-
CLINICAL_TRIALS trial_result · 2021-07-15Clinical Trial Update: Interaction Between Omeprazole and Gliclazide in CYP2C19 Normal/ Ultrarapid Metabolisers [Phase 1]
Phase 1 trial updating the interaction between omeprazole and gliclazide in CYP2C19 normal/ultrarapid metabolizers; completed with posted re…
-
CLINICAL_TRIALS trial_result · 2021-07-12Clinical Trial Update: A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH [Phase 3]
Phase 3 study update evaluating MSDC-0602K for glycemic control and cardiovascular outcomes in pre-diabetes/Type 2 diabetes with NAFLD/NASH;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2021-07-09FDA Approved: KERENDIA — Original Application (Bayer HealthCare Pharmaceuticals Inc.)
FDA approves Kerendia (finerenone) from the original application for adults with chronic kidney disease due to type 2 diabetes mellitus. It …
-
CLINICAL_TRIALS research · 2021-07-09Clinical Trial Update: A Study Using Swedish Registries to Find Out How Many People With Type 2 Diabetes Had Cardiovascular Disease and Started Treatment With Empagliflozin Between 2015 and 2017
A clinical trial update using Swedish registries to assess how many people with type 2 diabetes and cardiovascular disease started empaglifl…
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Multifactorial Intervention on Diabetes (MIDiab Study) [Phase 4]
Phase 4 clinical trial update for a multifactorial intervention in Type 2 diabetes (MIDiab Study) led by Shandong Provincial Hospital; curre…
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes [NA]
A terminated clinical trial investigating an app-based diabetes training program combined with the BD Nano Pen Needle for adults with type 2…
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Safety and Efficacy of Bexagliflozin Compared to Placebo as Add-on Therapy to Metformin in Type 2 Diabetes Subjects [Phase 3]
Phase 3 trial assessing safety and efficacy of bexagliflozin as add-on to metformin in type 2 diabetes; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Bexagliflozin Efficacy and Safety Trial [Phase 3]
Phase 3 trial update for Bexagliflozin evaluating efficacy and safety in Type 2 Diabetes Mellitus.
-
CLINICAL_TRIALS trial_result · 2021-07-07Clinical Trial Update: Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease [Phase 4]
Phase 4 trial evaluating the efficacy and safety of liraglutide in patients with type 2 diabetes and lower extremity arterial disease.
-
CLINICAL_TRIALS trial_result · 2021-07-02Clinical Trial Update: SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLD [Phase 4]
Phase 4 trial comparing an SGLT2 inhibitor with a sulfonylurea in type 2 diabetes patients with non-alcoholic fatty liver disease has comple…
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Comparison of Premixed Insulins Aspart 30, Aspart 70 and Aspart on Postprandial Lipids [Phase 4]
Phase 4 trial comparing premixed insulins Aspart 30, Aspart 70, and Aspart on postprandial lipids in Type 2 diabetes completed with results …
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: SGLT2 Inhibition in Combination With Diuretics in Heart Failure [Phase 4]
Phase 4 trial updating on SGLT2 inhibitors in combination with diuretics for heart failure and type 2 diabetes mellitus; results have been p…
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes [Phase 3]
Phase 3 trial comparing metformin glycinate to metformin hydrochloride for progression of type 2 diabetes; study status suspended.
-
FDA approval · 2021-06-28FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' supplemental application for Metformin Hydrochloride (generic), confirming the product's continued…
-
CLINICAL_TRIALS trial_result · 2021-06-28Clinical Trial Update: A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM [Phase 3]
Phase 3 trial update on DBPR108 combined with metformin for Type 2 Diabetes Mellitus has completed.
-
FDA approval · 2021-06-25FDA Approved: METFORMIN HYDROCHLORIDE EXTENDED RELEASE — Supplemental Application (TIME CAP LABORATORIES, INC)
FDA approved a supplemental application for Metformin Hydrochloride Extended Release from Time Cap Laboratories, Inc., bringing an extended-…
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control [Phase 3]
Phase 3 trial update reports on efficacy and bone safety of sotagliflozin 400 mg and 200 mg vs placebo in type 2 diabetes patients with inad…
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: A Study to Evaluate Safety and Effects of Sotagliflozin 400 and 200 mg on Glucose Control in Participants With Type 2 Diabetes, Severe Impairment of Kidney Function and Inadequate Blood Sugar Control [Phase 3]
Phase 3 trial evaluating safety and glucose control effects of sotagliflozin 400 mg and 200 mg in adults with type 2 diabetes and severe kid…
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Safety and Efficacy Study of Sotagliflozin on Glucose Control in Participants With Type 2 Diabetes, Moderate Impairment of Kidney Function, and Inadequate Blood Sugar Control [Phase 3]
Phase 3 trial assessing sotagliflozin for glucose control in adults with type 2 diabetes and moderate kidney impairment (Chronic Kidney Dise…
-
FDA approval · 2021-06-25FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' supplemental application for metformin hydrochloride.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: Efficacy and Safety of Sotagliflozin Versus Placebo in Patients With Type 2 Diabetes Mellitus Not Currently Treated With Antidiabetic Therapy [Phase 3]
A Phase 3 trial assessing sotagliflozin versus placebo in patients with Type 2 Diabetes Mellitus not previously treated with antidiabetic th…
-
CLINICAL_TRIALS trial_result · 2021-06-18Clinical Trial Update: Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure [Phase 4]
Phase 4 trial evaluating glucose-lowering strategies in patients with heart failure shows completed results.